Ameriprise Financial Inc Revolution Medicines, Inc. Transaction History

Ameriprise Financial Inc

$381 Billion
Q3 2024

A detailed history of Ameriprise Financial Inc transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 1,485,422 shares of RVMD stock, worth $64.3 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

1,485,422

Previous 1,472,290 0.89%

Holding current value

$64.3 Million

Previous $57.1 Million 17.79%

% of portfolio

0.02%

Previous 0.02%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$36.92 - $47.94 $484,833 - $629,548	13,132 Added 0.89%	1,485,422 $67.3 Million
Q2 2024 Aug 14, 2024	SELL	$30.14 - $40.68 $6.7 Million - $9.04 Million	-222,211 Reduced 13.11%	1,472,290 $57.1 Million
Q1 2024 May 15, 2024	BUY	$26.56 - $33.55 $1.9 Million - $2.4 Million	71,480 Added 4.4%	1,694,501 $54.6 Million
Q4 2023 Feb 14, 2024	BUY	$18.35 - $34.12 $7.54 Million - $14 Million	411,165 Added 33.93%	1,623,021 $46.5 Million
Q3 2023 Nov 14, 2023	SELL	$25.17 - $35.05 $298,742 - $416,008	-11,869 Reduced 0.97%	1,211,856 $33.5 Million
Q2 2023 Aug 14, 2023	BUY	$20.28 - $27.0 $2.02 Million - $2.69 Million	99,767 Added 8.88%	1,223,725 $32.7 Million
Q1 2023 May 15, 2023	BUY	$20.76 - $30.09 $8.78 Million - $12.7 Million	423,035 Added 60.35%	1,123,958 $24.3 Million
Q4 2022 Feb 14, 2023	SELL	$17.68 - $25.53 $5.17 Million - $7.46 Million	-292,140 Reduced 29.42%	700,923 $16.7 Million
Q3 2022 Nov 14, 2022	SELL	$17.46 - $26.0 $143,957 - $214,370	-8,245 Reduced 0.82%	993,063 $19.6 Million
Q2 2022 Aug 15, 2022	BUY	$14.54 - $27.17 $447,744 - $836,672	30,794 Added 3.17%	1,001,308 $19.5 Million
Q1 2022 May 16, 2022	BUY	$17.31 - $26.4 $159,563 - $243,355	9,218 Added 0.96%	970,514 $24.8 Million
Q4 2021 Feb 14, 2022	BUY	$24.35 - $33.7 $50,380 - $69,725	2,069 Added 0.22%	961,296 $24.2 Million
Q3 2021 Nov 15, 2021	BUY	$23.95 - $33.41 $520,720 - $726,400	21,742 Added 2.32%	959,227 $26.4 Million
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $15 Million - $24.5 Million	517,478 Added 123.21%	937,485 $29.7 Million
Q1 2021 May 17, 2021	BUY	$37.21 - $54.43 $5.53 Million - $8.09 Million	148,682 Added 54.8%	420,007 $19.3 Million
Q4 2020 Feb 12, 2021	BUY	$30.19 - $45.49 $6.67 Million - $10.1 Million	221,086 Added 440.07%	271,325 $10.7 Million
Q3 2020 Nov 16, 2020	BUY	$22.61 - $34.8 $131,024 - $201,665	5,795 Added 13.04%	50,239 $1.75 Million
Q2 2020 Aug 14, 2020	SELL	$19.65 - $39.34 $375,138 - $751,039	-19,091 Reduced 30.05%	44,444 $1.4 Million
Q1 2020 May 15, 2020	BUY	$20.0 - $34.08 $1.27 Million - $2.17 Million	63,535 New	63,535 $1.39 Million

Others Institutions Holding RVMD

# of Institutions

266

Shares Held

161M

Call Options Held

260K

Put Options Held

620K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Revolution Medicines, Inc. Transaction History